Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany德国针对季节性流感的常规儿童疫苗接种的成本效益VALUE IN HEALTHIF62021-01-019OAAI
Hyperlipidemias in elderly patients: results from the Berlin Aging Study II (BASEII), a cross-sectional studyLIPIDS IN HEALTH AND DISEASEIF4.22020-05-1425OAAI
Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling studyBMC MEDICINEIF8.32018-01-0919OAAI
Analysing published global Ebola Virus Disease research using social network analysisPLOS NEGLECTED TROPICAL DISEASESIF3.42017-10-0917OAAI
Is the impact of childhood influenza vaccination less than expected: a transmission modelling study儿童流感疫苗接种的影响是否低于预期: 一项传播模型研究BMC INFECTIOUS DISEASESIF32017-04-1120OAAI
COMPLICATIONS AND HEALTH CARE COSTS OF INFLUENZA IN GERMANY: A RETROSPECTIVE CLAIMS DATA ANALYSISVALUE IN HEALTHIF62016-11-010OAAI
A SYSTEMATIC REVIEW OF UTILITIY WEIGHTS FOR INFLUENZA AND INFLUENZA-LIKE ILLNESSVALUE IN HEALTHIF62016-11-013OAAI
Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccinationHUMAN VACCINES & IMMUNOTHERAPEUTICSIF3.52016-02-0221OAAI
COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION OF ELDERLY IN GERMANYVALUE IN HEALTHIF62015-11-012OAAI
METHODS FOR HEALTH ECONOMIC EVALUATIONS OF VACCINES - RESULTS FROM AN INTERNATIONAL EXPERT-WORKSHOPVALUE IN HEALTHIF62014-11-011OAAI
TOO EARLY OR TOO LATE? IMPACT OF DIFFERENT HERPES ZOSTER VACCINE'S WANING RATES ON AGE-SPECIFIC INCREMENTAL COST-EFFECTIVENESS RATIOVALUE IN HEALTHIF62013-11-010OAAI